Smith & Nephew plc (SNN)

Price$30.61

Value ScoreB

Growth ScoreC

Momentum ScoreC

Favorite Metrics

Price vs S&P 500 (26W)-16.82%

Price vs S&P 500 (4W)4.95%

VGM Score61.28

Market Capitalization$9.62B

P/E Ratio (Annual)20.54x

Indicated Dividend Yield (Annual)2.56%

All Metrics

P/CF (Annual)9.99x

Book Value / Share (Quarterly)$6.22

P/TBV (Annual)3.17x

Indicated Dividend (Annual)$29.04

Revenue Growth (3Y)5.73%

Cash Flow / Share (Quarterly)$1.00

Payout Ratio (TTM)52.80%

Price vs S&P 500 (YTD)-15.55%

Gross Margin (TTM)68.01%

Net Profit Margin (TTM)10.14%

EPS (TTM)$0.72

10-Day Avg Trading Volume2.37M

EPS Excl Extra (TTM)$0.72

Revenue Growth (5Y)6.21%

EPS (Annual)$0.72

Dividend / Share (Annual)$0.38

ROI (Annual)7.25%

Gross Margin (Annual)68.25%

Net Profit Margin (5Y Avg)7.26%

Cash / Share (Quarterly)$0.66

P/E Basic Excl Extra (TTM)20.54x

Revenue Growth QoQ (YoY)7.38%

EPS Growth (5Y)6.98%

P/E Normalized (Annual)20.54x

ROA (Last FY)5.98%

Revenue Growth TTM (YoY)6.09%

EBITD / Share (TTM)$1.11

ROE (5Y Avg)7.67%

Operating Margin (TTM)12.88%

Cash Flow / Share (Annual)$1.00

P/B Ratio2.43x

P/B Ratio (Quarterly)2.64x

Net Income / Employee (Annual)$36,800

EV / Revenue (TTM)2.53x

Net Interest Coverage (TTM)4.80x

ROA (TTM)5.91%

EPS Growth QoQ (YoY)70.05%

EV / EBITDA (TTM)16.13x

EPS Incl Extra (Annual)$0.72

Current Ratio (Annual)2.57x

Quick Ratio (Quarterly)1.25x

3-Month Avg Trading Volume1.95M

52-Week Price Return3.57%

EV / Free Cash Flow (Annual)18.32x

P/E Incl Extra (TTM)20.54x

Revenue / Employee (TTM)$362,800

Tangible BV / Share (Quarterly)$5.19

P/S Ratio (Annual)2.08x

Asset Turnover (Annual)0.59x

52-Week High$1441.50

Operating Margin (5Y Avg)10.58%

EPS Excl Extra (Annual)$0.72

CapEx CAGR (5Y)-0.46%

Tangible BV CAGR (5Y)3.05%

26-Week Price Return-8.90%

Quick Ratio (Annual)1.18x

13-Week Price Return-15.66%

Total Debt / Equity (Annual)0.63x

Current Ratio (Quarterly)2.57x

Enterprise Value$15.61B

Revenue / Share Growth (5Y)6.31%

Asset Turnover (TTM)0.58x

Book Value / Share Growth (5Y)0.64%

Revenue / Employee (Annual)$362,800

Inventory Turnover (Annual)0.87x

Pretax Margin (Annual)12.64%

Cash / Share (Annual)$0.66

3-Month Return Std Dev25.30%

Gross Margin (5Y Avg)70.14%

Net Income / Employee (TTM)$36,800

EBITDA CAGR (5Y)14.32%

EBITDA Interim CAGR (5Y)0.22%

ROE (Last FY)11.82%

Net Interest Coverage (Annual)5.93x

EPS Basic Excl Extra (Annual)$0.72

P/FCF (TTM)15.07x

Receivables Turnover (TTM)4.41x

EV / Free Cash Flow (TTM)18.32x

Total Debt / Equity (Quarterly)0.63x

EPS Incl Extra (TTM)$0.72

Receivables Turnover (Annual)5.57x

ROI (TTM)7.10%

Dividend Growth Rate (5Y)0.41%

P/S Ratio (TTM)2.08x

Pretax Margin (5Y Avg)8.44%

Revenue / Share (Annual)$7.06

Tangible BV / Share (Annual)$5.19

Forward P/E12.38x

Free OCF CAGR (5Y)11.61%

Price vs S&P 500 (52W)-20.80%

P/E Ratio (TTM)20.54x

EPS Growth TTM (YoY)52.27%

Year-to-Date Return-7.39%

5-Day Price Return4.75%

EPS Normalized (Annual)$0.72

ROA (5Y Avg)3.93%

Net Profit Margin (Annual)10.14%

Month-to-Date Return3.24%

Cash Flow / Share (TTM)$0.75

EBITD / Share (Annual)$1.18

EPS Growth (3Y)41.07%

Operating Margin (Annual)12.88%

LT Debt / Equity (Annual)0.57x

P/CF (TTM)9.99x

ROI (5Y Avg)4.77%

P/E Excl Extra (TTM)20.54x

LT Debt / Equity (Quarterly)0.57x

EPS Basic Excl Extra (TTM)$0.72

P/TBV (Quarterly)3.17x

Payout Ratio (Annual)52.80%

P/B Ratio (Annual)2.64x

Dividend / Share (TTM)$0.38

Inventory Turnover (TTM)0.88x

Pretax Margin (TTM)12.64%

Book Value / Share (Annual)$6.22

Price vs S&P 500 (13W)-23.92%

Net Margin Growth (5Y)0.64%

Dividend Yield (TTM)2.57%

Beta1.17x

P/FCF (Annual)15.07x

Revenue / Share (TTM)$7.12

ROE (TTM)11.55%

52-Week Low$1059.50

vGradeB

gGradeC

mGradeC

vgmGradeB

Show chart for

Analyst Recommendations

Mar 2026

Apr 2026

May 2026

Jun 2026

3.79

3.71

3.79

Industry Peers — Orthopedic & Prosthetic Devices(33)

Symbol	Value Score	Growth Score	Momentum Score	Price
SNNSmith & Nephew plc	B	C	C	$30.61
ISRGIntuitive Surgical Inc.	F	B	C	$422.06
EWEdwards Lifesciences Corp	D	C	C	$85.96
STESTERIS plc	C	B	C	$212.35
ZBHZimmer Biomet Holdings, Inc.	B	C	C	$87.33
ALGNAlign Technology Inc	B	C	C	$167.74
MSAMine Safety Incorporated	B	C	C	$161.30
ESTAEstablishment Labs Holdings Inc.	F	A	B	$74.31
ENOVEnovis Corporation	B	D	C	$23.78
CDRECadre Holdings, Inc.	C	C	D	$30.01
AVNSAvanos Medical, Inc.	B	D	A	$25.05

About

Smith & Nephew is a UK-based medical device company with three core segments: orthopedic devices (41% of revenue), sports medicine and arthroscopic technologies (30%), and advanced wound care (29%). The company generates over half its revenue from North America, with the remainder split between developed and emerging markets.